Header Logo

Youssef Errami

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
DepartmentPostDoc
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zerfaoui M, Patel D, Zhang Y, Schinazi RF, Errami Y. Loss of the aryl hydrocarbon receptor promotes cancer cell resistance to BRAFV600E targeted therapies. Signal Transduct Target Ther. 2025 May 14; 10(1):158. PMID: 40360477; PMCID: PMC12075852.
      Citations:    Fields:    
    2. Alhassan SO, Abd Elmageed ZY, Errami Y, Wang G, Abi-Rached JA, Kandil E, Zerfaoui M. BRAFV600E-PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization. Clin Transl Med. 2025 03; 15(3):e70251. PMID: 40045459; PMCID: PMC11882472.
      Citations:    
    3. Renauer P, Park JJ, Bai M, Acosta A, Lee WH, Lin GH, Zhang Y, Dai X, Wang G, Errami Y, Wu T, Clark P, Ye L, Yang Q, Chen S. Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function. Cancer Immunol Res. 2023 08 03; 11(8):1068-1084. PMID: 37253111; PMCID: PMC10527769.
      Citations:    
    4. Mueller LE, Issa PP, Hussein MH, Elshazli RM, Haidari M, Errami Y, Shama M, Fawzy MS, Kandil E, Toraih E. Clinical outcomes and tumor microenvironment response to radiofrequency ablation therapy: a systematic review and meta-analysis. Gland Surg. 2024 Jan 29; 13(1):4-18. PMID: 38323236; PMCID: PMC10839696.
      Citations:    
    5. Ruiz E, Kandil E, Alhassan S, Toraih E, Errami Y, Elmageed ZYA, Zerfaoui M. An Integrative Multi-Omics Analysis of The Molecular Links between Aging and Aggressiveness in Thyroid Cancers. Aging Dis. 2023 Jun 01; 14(3):992-1012. PMID: 37191407; PMCID: PMC10187705.
      Citations:    
    6. Ruiz EM, Alhassan SA, Errami Y, Abd Elmageed ZY, Fang JS, Wang G, Brooks MA, Abi-Rached JA, Kandil E, Zerfaoui M. A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma. Int J Mol Sci. 2023 May 07; 24(9). PMID: 37176114; PMCID: PMC10178962.
      Citations:    
    7. Renauer P, Park JJ, Bai M, Acosta A, Lee WH, Lin GH, Zhang Y, Dai X, Wang G, Errami Y, Wu T, Clark P, Ye L, Yang Q, Chen S. Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function. bioRxiv. 2023 Mar 15. PMID: 36993638; PMCID: PMC10055032.
      Citations:    
    8. Toraih EA, Fawzy MS, Ning B, Zerfaoui M, Errami Y, Ruiz EM, Hussein MH, Haidari M, Bratton M, Tortelote GG, Hilliard S, Nilubol N, Russell JO, Shama MA, El-Dahr SS, Moroz K, Hu T, Kandil E. A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence. Cancers (Basel). 2022 Aug 26; 14(17). PMID: 36077665; PMCID: PMC9454675.
      Citations:    
    9. Yousafzai MS, Yadav V, Amiri S, Staddon MF, Errami Y, Jaspard G, Banerjee S, Murrell M. Cell-Matrix Elastocapillary Interactions Drive Pressure-based Wetting of Cell Aggregates. Phys Rev X. 2022 Jul-Sep; 12(3). PMID: 38009085; PMCID: PMC10673637.
      Citations:    
    10. Zerfaoui M, Tsumagari K, Toraih E, Errami Y, Ruiz E, Elaasar MSM, Krzysztof M, Sholl AB, Magdeldin S, Soudy M, Abd Elmageed ZY, Boulares AH, Kandil E. Nuclear interaction of Arp2/3 complex and BRAFV600E promotes aggressive behavior and vemurafenib resistance of thyroid cancer. Am J Cancer Res. 2022; 12(7):3014-3033. PMID: 35968344; PMCID: PMC9360225.
      Citations:    
    11. Ye L, Park JJ, Peng L, Yang Q, Chow RD, Dong MB, Lam SZ, Guo J, Tang E, Zhang Y, Wang G, Dai X, Du Y, Kim HR, Cao H, Errami Y, Clark P, Bersenev A, Montgomery RR, Chen S. A genome-scale gain-of-function CRISPR screen in CD8 T?cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metab. 2022 04 05; 34(4):595-614.e14. PMID: 35276062; PMCID: PMC8986623.
      Citations:    
    12. Yousafzai MS, Yadav V, Amiri S, Errami Y, Amiri S, Murrell M. Active Regulation of Pressure and Volume Defines an Energetic Constraint on the Size of Cell Aggregates. Phys Rev Lett. 2022 Jan 28; 128(4):048103. PMID: 35148133.
      Citations:    
    13. Zerfaoui M, Toraih E, Ruiz E, Errami Y, Attia AS, Krzysztof M, Abd Elmageed ZY, Kandil E. Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells. Cancers (Basel). 2022 Jan 09; 14(2). PMID: 35053476; PMCID: PMC8773521.
      Citations:    
    14. Toraih EA, Fawzy MS, Hussein MH, El-Labban MM, Ruiz EML, Attia AA, Halat S, Moroz K, Errami Y, Zerfaoui M, Kandil E. MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis. Cancers (Basel). 2021 Sep 16; 13(18). PMID: 34572876; PMCID: PMC8468667.
      Citations:    
    15. Ghonim MA, Ibba SV, Tarhuni AF, Errami Y, Luu HH, Dean MJ, El-Bahrawy AH, Wyczechowska D, Benslimane IA, Del Valle L, Al-Khami AA, Ochoa AC, Boulares AH. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J Immunother Cancer. 2021 01; 9(1). PMID: 33495297; PMCID: PMC7839867.
      Citations:    
    16. Wang G, Chow RD, Zhu L, Bai Z, Ye L, Zhang F, Renauer PA, Dong MB, Dai X, Zhang X, Du Y, Cheng Y, Niu L, Chu Z, Kim K, Liao C, Clark P, Errami Y, Chen S. CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discov. 2020 12; 10(12):1912-1933. PMID: 32887696; PMCID: PMC7710536.
      Citations:    
    17. Wang G, Chow RD, Bai Z, Zhu L, Errami Y, Dai X, Dong MB, Ye L, Zhang X, Renauer PA, Park JJ, Shen L, Ye H, Fuchs CS, Chen S. Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity. Nat Immunol. 2019 11; 20(11):1494-1505. PMID: 31611701; PMCID: PMC6858551.
      Citations:    
    18. Ye L, Park JJ, Dong MB, Yang Q, Chow RD, Peng L, Du Y, Guo J, Dai X, Wang G, Errami Y, Chen S. In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nat Biotechnol. 2019 Nov; 37(11):1302-1313. PMID: 31548728; PMCID: PMC6834896.
      Citations:    
    19. Dong MB, Wang G, Chow RD, Ye L, Zhu L, Dai X, Park JJ, Kim HR, Errami Y, Guzman CD, Zhou X, Chen KY, Renauer PA, Du Y, Shen J, Lam SZ, Zhou JJ, Lannin DR, Herbst RS, Chen S. Systematic Immunotherapy Target Discovery Using Genome-Scale In?Vivo CRISPR Screens in CD8?T Cells. Cell. 2019 Aug 22; 178(5):1189-1204.e23. PMID: 31442407; PMCID: PMC6719679.
      Citations:    
    20. Chow RD, Wang G, Ye L, Codina A, Kim HR, Shen L, Dong MB, Errami Y, Chen S. In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens. Nat Methods. 2019 05; 16(5):405-408. PMID: 30962622; PMCID: PMC6592845.
      Citations:    
    21. Dai X, Park JJ, Du Y, Kim HR, Wang G, Errami Y, Chen S. One-step generation of modular CAR-T cells with AAV-Cpf1. Nat Methods. 2019 03; 16(3):247-254. PMID: 30804551; PMCID: PMC6519746.
      Citations:    
    22. Codina A, Renauer PA, Wang G, Chow RD, Park JJ, Ye H, Zhang K, Dong MB, Gassaway B, Ye L, Errami Y, Shen L, Chang A, Jain D, Herbst RS, Bosenberg M, Rinehart J, Fan R, Chen S. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In?Vivo. Cell Syst. 2019 02 27; 8(2):136-151.e7. PMID: 30797773; PMCID: PMC6592847.
      Citations:    
    23. Loughran SJ, Comoglio F, Hamey FK, Giustacchini A, Errami Y, Earp E, G?ttgens B, Jacobsen SEW, Mead AJ, Hendrich B, Green AR. Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. J Exp Med. 2017 Oct 02; 214(10):3085-3104. PMID: 28899870; PMCID: PMC5626393.
      Citations:    
    24. Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S, Renauer P, Bilguvar K, Gunel M, Sharp PA, Zhang F, Platt RJ, Chen S. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci. 2017 Oct; 20(10):1329-1341. PMID: 28805815; PMCID: PMC5614841.
      Citations:    
    25. Errami Y, Brim H, Oumouna-Benachour K, Oumouna M, Naura AS, Kim H, Ju J, Davis CJ, Kim JG, Ashktorab H, Fallon K, Xu M, Zhang J, Del Valle L, Boulares AH. ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability. PLoS One. 2013; 8(2):e57871. PMID: 23451280; PMCID: PMC3579889.
      Citations:    
    26. Errami Y, Naura AS, Kim H, Ju J, Suzuki Y, El-Bahrawy AH, Ghonim MA, Hemeida RA, Mansy MS, Zhang J, Xu M, Smulson ME, Brim H, Boulares AH. Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis. J Biol Chem. 2013 Feb 01; 288(5):3460-8. PMID: 23229555; PMCID: PMC3561564.
      Citations:    
    27. Naura AS, Kim H, Ju J, Rodriguez PC, Jordan J, Catling AD, Rezk BM, Abd Elmageed ZY, Pyakurel K, Tarhuni AF, Abughazleh MQ, Errami Y, Zerfaoui M, Ochoa AC, Boulares AH. Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor ?B-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase. J Biol Chem. 2013 Jan 18; 288(3):1458-68. PMID: 23184953; PMCID: PMC3548459.
      Citations:    
    28. Abd Elmageed ZY, Naura AS, Errami Y, Zerfaoui M. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport. Cell Signal. 2012 Jan; 24(1):1-8. PMID: 21840394.
      Citations:    
    29. Kim H, Naura AS, Errami Y, Ju J, Boulares AH. Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP. Mol Med. 2011 Sep-Oct; 17(9-10):893-900. PMID: 21607289; PMCID: PMC3188885.
      Citations:    
    30. Datta R, Naura AS, Zerfaoui M, Errami Y, Oumouna M, Kim H, Ju J, Ronchi VP, Haas AL, Boulares AH. PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy. 2011 Jul; 66(7):853-61. PMID: 21276008; PMCID: PMC3150522.
      Citations:    
    31. Ju J, Naura AS, Errami Y, Zerfaoui M, Kim H, Kim JG, Abd Elmageed ZY, Abdel-Mageed AB, Giardina C, Beg AA, Smulson ME, Boulares AH. Phosphorylation of p50 NF-kappaB at a single serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatment. J Biol Chem. 2010 Dec 24; 285(52):41152-60. PMID: 20966071; PMCID: PMC3003413.
      Citations:    
    32. Naura AS, Zerfaoui M, Kim H, Abd Elmageed ZY, Rodriguez PC, Hans CP, Ju J, Errami Y, Park J, Ochoa AC, Boulares AH. Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. J Immunol. 2010 Sep 01; 185(5):3076-85. PMID: 20668217; PMCID: PMC3077076.
      Citations:    
    33. Zerfaoui M, Errami Y, Naura AS, Suzuki Y, Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, Koochekpour S, Catling A, Boulares AH. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol. 2010 Aug 01; 185(3):1894-902. PMID: 20610652; PMCID: PMC2910824.
      Citations:    
    34. Naura AS, Hans CP, Zerfaoui M, Errami Y, Ju J, Kim H, Matrougui K, Kim JG, Boulares AH. High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors. Lab Invest. 2009 Nov; 89(11):1243-51. PMID: 19752857; PMCID: PMC2784111.
      Citations:    
    35. Zerfaoui M, Naura AS, Errami Y, Hans CP, Rezk BM, Park J, Elsegeiny W, Kim H, Lord K, Kim JG, Boulares AH. Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines. J Leukoc Biol. 2009 Dec; 86(6):1385-92. PMID: 19741160; PMCID: PMC2780916.
      Citations:    
    36. Naura AS, Datta R, Hans CP, Zerfaoui M, Rezk BM, Errami Y, Oumouna M, Matrougui K, Boulares AH. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J. 2009 Feb; 33(2):252-62. PMID: 18829681.
      Citations:    
    Errami's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (205)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _